Activist Investor Nelson Peltz' Trian Fund Cut Back On This Stock In Q4, But Held Steady On GE Aerospace
Activist investor Trian Fund Management, led by Nelson Peltz, increased stakes in major industrial and healthcare names while trimming more cyclical financial positions in the fourth quarter, according to its latest quarterly 13F filing for the period ended Dec. 31, 2025.
What’s New In Trian's Q4 13F?
The firm slightly increased its stake in GE Aerospace, adding just over 500 shares to bring the total to 4.03 million shares. The incremental buy pushed the position's total market value to roughly $1.24 billion, up from $1.21 billion at the end of Q3. The move reflects continued confidence in the aerospace giant amid strong defense and commercial aviation demand.
In healthcare, GE HealthCare Technologies saw a tiny bump, with Trian adding 15 shares, bringing its total to 4,044. While the overall value of the stake is still small at about $332,000, the move signals that Trian remains interested in the long-term potential of medical imaging and diagnostics businesses.
The most dramatic change came in the financial sector. Trian slashed its Invesco position by nearly 12 million shares, reducing the holding from 14.6 million shares to just under 3 million. In dollar terms, that's a reduction of roughly $258 million, leaving the fund with a $78 million position. This massive trimming indicates a decisive pivot away from broad-based financial exposure.
Other positions, including Wendy's, Ferguson, and Solventum, were largely steady.
The Bigger Picture: Peltz, Buyouts & Activist Strategies
Trian's reported Q4 2025 portfolio value was roughly $3.98 billion with seven disclosed holdings. That reflects a concentrated lineup amid the firm’s ongoing activist and strategic pivot, including the outright $7.4 billion buyout of asset manager Janus Henderson in partnership with General Catalyst.
Peltz has signaled a potential shift toward more outright buyouts rather than traditional proxy fights. Earlier this month, the billionaire businessman noted at a WSJ event that buying companies directly can enable faster strategy implementation than negotiating with existing leadership. That is a notable flavor in markets that have seen heightened activist activity and merger momentum heading into 2026.
What’s Going On With GE Aerospace?
Aside from Janus, the fund’s next top bet is GE Aerospace.
The Ohio-based company has benefited from resilient defense and commercial aviation demand, with strong order backlogs and engine programs ramping production. Its stock is up over 55% in the past year, and closed up 3.7% at $327.08, as per data from Benzinga Pro.
Benzinga’s Edge Rankings also indicate favourable price trends across time periods and strong Momentum and Quality rankings.
Image via Shutterstock
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
"Predicting Your Prediction" Intensifies Tech Stock Sell-off! After $2.3 Trillion Market Value Evaporates, Has the "Hot Money" Mechanical Selling Still Not Subsided?
The Nasdaq 100 Index fell by 6.4%, wiping out $2.3 trillion in market capitalization. The core reason behind this decline is concerns that a comprehensive victory by the Democratic Party could lead to stricter regulations on AI development. Systematic funds, which typically follow the stock market's trend and respond to price fluctuations and momentum signals, were thus forced to reduce their investments, accelerating the downturn. The selling pressure from systematic strategies may not be over yet; it is expected that in the coming days, portfolios targeting volatility will sell at least $50 billion worth of stocks.
The midterm election tears open the "abyss" of AI trading, facing a moment of reckoning for trillion-dollar capital expenditure narratives
For months, investors have been worried about a series of risks behind the AI (artificial intelligence) capital expenditure "money tree." This week, the market finally pressed the panic selling button.
Crypto prices
More
